中文 | English
Return
Total: 379 , 1/38
Show Home Prev Next End page: GO
Author:( Zhaohui LIU)

1.Protective effect of ascorbic acid on dexamethasone-induced intraocular hypertension in rabbit

Zhaohui LIU

Journal of Chongqing Medical University 1987;0(01):-

2.Clinical analysis of 19 cases with acute colonic pseudoobstruction

Zhaohui LIU

Chinese Journal of Primary Medicine and Pharmacy 2009;16(3):412-413

3.Biomechanical difference between Twin-Block appliance and straight wire appliance in the early treatment of Class II division 1 malocclusion

Zhaohui JIN ; Wenhui LIU

Chinese Journal of Tissue Engineering Research 2015;(12):1842-1845

4.Literature Analysis on Shenmai Injection-induced Adverse Reactions:Survey of 60 Cases

Zhaohui SHENG ; Jiangjiao LIU

China Pharmacy 2005;0(20):-

5.The effects of pioglitazone on the expression of ICAM-1 mRNA in the ischemia-reperfusion brain tissues in SD rats

Zhaohui TIAN ; Zunjing LIU

Chinese Journal of Behavioral Medicine and Brain Science 2009;18(7):594-595

6.Continuous intravenous infusion of furosemide and dopamine combined with Shenmai on treatment of refractory heart failure

Yingjian LIAO ; Zhaohui LIU

Chinese Journal of Postgraduates of Medicine 2011;34(7):17-19

7.Congenital anti-candida of human vaginal epithelial cells

Zhaohui LIU ; Lei CHEN

Journal of Peking University(Health Sciences) 2004;0(02):-

8.25S rDNA genotype and antifungal susceptibility of vaginal Candida albicans

Xu ZHANG ; Zhaohui LIU

Chinese Journal of Obstetrics and Gynecology 2016;51(4):279-284

9.Effect of Phlebitis Mixture on Complications after Endovenous Laser Treatment for Varicose Great Saphenous Vein

Zhaohui CHEN ; Jiqian LIU

Chinese Journal of Rehabilitation Theory and Practice 2009;15(9):863-864

10.Correlation analysis of Sirt1 gene variant and susceptibility to chronic obstructive pulmonary disease

Zhaohui WAN ; Bing LIU ; Yong LIN

Clinical Medicine of China 2016;32(7):603-606

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 379 , 1/38 Show Home Prev Next End page: GO